Real-time disaster intelligence, alerts, and response tools.
Tuesday, April 21, 2026
[ad_1] TOKYO, Oct. 10, 2024 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) announced that VEOZA™ (fezolinetant)*, its first-in-class treatment for moderate to severe vasomotor symptoms (VMS) associated with menopause, will be […]
[ad_1] CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Oct. 9, 2024 /PRNewswire/ — Harbour BioMed (the “Company”; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on […]
[ad_1] CZ Biohub New York is catalyzing collaboration among scientists in the New York area from Columbia University, The Rockefeller University, and Yale University. NEW YORK, Oct. 9, 2024 /PRNewswire/ — Today, leadership from Chan Zuckerberg […]
[ad_1] HERZLIYA, Israel and CALGARY, Alberta, Oct. 9, 2024 /PRNewswire/ — Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (“Innocan” or the “Company”), a pioneer in the pharmaceutical and biotechnology industries, is pleased to […]
[ad_1] “The Market is growing rapidly, driven by its potential to transform healthcare by enabling personalized treatment and targeted therapies. With increasing investment and innovation, this market is expected to revolutionize the way diseases are […]
